Advanced 20+ Drug Delivery System Formulations (CBD, THC, CBG) for International Medical & Wellness Market Segments
Complete Formulary of Medical Cannabis and Wellness Products
The portfolio contains various doses and ratios of cannabinoids
The portfolio contains a diverse range of formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids such as cannabidiol (“CBD”), cannabigerol (“CBG”), and tetrahydrocannabinol (“THC”).
The formulary is supported by ongoing consumer, patient, and medical community education and training including https://www.avicanna.com/avicenna-academy.
The brand is currently available nationwide to patients in medical channels across Canada including MyMedi.ca. RHO Phyto is also accessible through several other medical portals such as The University Health Network (“UHN”) and the Odette Cancer Centre pharmacy of Sunnybrook Health Science Centre, a major hospital group in Canada.
Canadian adult-use channels
Medical Cannabis by Shoppers Commercial Portal
Including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data
Canada’s leading pharmacy retailer with more than 30,000+ registered cannabis patients
Collaborative education and training strategy with clinics in the medical community
Successful segmentation medical patients and aging population
sales are to 41+ years of age
Sunnybrook Hospital: first medical cannabis brand to be available for dispensing in major hospital pharmacy
UHN-RWET: University Health Network medical cannabis real world evidence study
Commercial across Canada, Colombia and Barbados
Commercial across 3 channels in Canada including Adult Use, Clinical and Medical in partnership with Medical Cannabis by Shoppers
Adult use channel. Establishing the wellness category in partnership with retailers across – ON, AB, NB, SK and NB